Bumrungrad Hospital PCL (BKK:BH)
Thailand
· Delayed Price · Currency is THB 163.50
-2.50 (-1.51%)
Apr 25, 2025, 11:41 AM ICT
Bumrungrad Hospital PCL Income Statement
Financials in millions THB. Fiscal year is January - December.
Millions THB. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Operating Revenue | 25,322 | 25,718 | 25,376 | 20,721 | 12,460 | 12,362 | Upgrade
|
| Other Revenue | 182.77 | 144.87 | 170.76 | 186.97 | 144.1 | 77.83 | Upgrade
|
| Revenue | 25,505 | 25,862 | 25,547 | 20,908 | 12,605 | 12,440 | Upgrade
|
| Revenue Growth (YoY) | -1.99% | 1.23% | 22.19% | 65.87% | 1.32% | -32.97% | Upgrade
|
| Cost of Revenue | 12,397 | 12,503 | 12,895 | 11,099 | 7,731 | 7,677 | Upgrade
|
| Gross Profit | 13,108 | 13,359 | 12,652 | 9,808 | 4,874 | 4,763 | Upgrade
|
| Selling, General & Admin | 4,235 | 4,171 | 4,180 | 3,798 | 3,296 | 3,394 | Upgrade
|
| Operating Expenses | 4,235 | 4,171 | 4,180 | 3,798 | 3,296 | 3,394 | Upgrade
|
| Operating Income | 8,873 | 9,188 | 8,472 | 6,010 | 1,578 | 1,368 | Upgrade
|
| Interest Expense | -8.25 | -8.33 | -2.39 | -3.55 | -119.76 | -127.62 | Upgrade
|
| Interest & Investment Income | 281.38 | 279.47 | 140.95 | 45.95 | 68.78 | 127.89 | Upgrade
|
| Earnings From Equity Investments | -0.42 | -0.43 | -0.9 | -0.51 | -68.87 | -2.38 | Upgrade
|
| Currency Exchange Gain (Loss) | -34.28 | -22.73 | 28.06 | -3.27 | -1.91 | 4.7 | Upgrade
|
| Pretax Income | 9,111 | 9,436 | 8,638 | 6,049 | 1,456 | 1,371 | Upgrade
|
| Income Tax Expense | 1,535 | 1,604 | 1,583 | 1,072 | 215.85 | 149.68 | Upgrade
|
| Earnings From Continuing Operations | 7,577 | 7,832 | 7,055 | 4,977 | 1,240 | 1,221 | Upgrade
|
| Minority Interest in Earnings | -52.79 | -57.33 | -48.68 | -38.54 | -24.35 | -17.12 | Upgrade
|
| Net Income | 7,524 | 7,775 | 7,006 | 4,938 | 1,216 | 1,204 | Upgrade
|
| Net Income to Common | 7,524 | 7,775 | 7,006 | 4,938 | 1,216 | 1,204 | Upgrade
|
| Net Income Growth | 1.56% | 10.96% | 41.88% | 306.21% | 0.96% | -67.87% | Upgrade
|
| Shares Outstanding (Basic) | 795 | 795 | 795 | 795 | 795 | 782 | Upgrade
|
| Shares Outstanding (Diluted) | 867 | 867 | 867 | 867 | 867 | 867 | Upgrade
|
| EPS (Basic) | 9.46 | 9.78 | 8.81 | 6.21 | 1.53 | 1.54 | Upgrade
|
| EPS (Diluted) | 8.67 | 8.96 | 8.08 | 5.69 | 1.40 | 1.39 | Upgrade
|
| EPS Growth | 1.52% | 10.89% | 42.00% | 306.43% | 0.72% | -67.82% | Upgrade
|
| Free Cash Flow | 7,133 | 7,455 | 5,522 | 5,067 | 2,753 | 1,372 | Upgrade
|
| Free Cash Flow Per Share | 8.22 | 8.59 | 6.37 | 5.84 | 3.17 | 1.58 | Upgrade
|
| Dividend Per Share | 5.000 | 5.000 | 4.500 | 3.500 | 3.200 | 3.200 | Upgrade
|
| Dividend Growth | 11.11% | 11.11% | 28.57% | 9.38% | - | - | Upgrade
|
| Gross Margin | 51.39% | 51.66% | 49.53% | 46.91% | 38.66% | 38.29% | Upgrade
|
| Operating Margin | 34.79% | 35.53% | 33.16% | 28.75% | 12.52% | 11.00% | Upgrade
|
| Profit Margin | 29.50% | 30.06% | 27.43% | 23.62% | 9.64% | 9.68% | Upgrade
|
| Free Cash Flow Margin | 27.97% | 28.82% | 21.62% | 24.23% | 21.84% | 11.03% | Upgrade
|
| EBITDA | 9,789 | 10,115 | 9,405 | 6,938 | 2,553 | 2,387 | Upgrade
|
| EBITDA Margin | 38.38% | 39.11% | 36.81% | 33.18% | 20.26% | 19.19% | Upgrade
|
| D&A For EBITDA | 916.03 | 927.23 | 933.08 | 927.49 | 975.86 | 1,018 | Upgrade
|
| EBIT | 8,873 | 9,188 | 8,472 | 6,010 | 1,578 | 1,368 | Upgrade
|
| EBIT Margin | 34.79% | 35.53% | 33.16% | 28.75% | 12.52% | 11.00% | Upgrade
|
| Effective Tax Rate | 16.84% | 17.00% | 18.32% | 17.72% | 14.83% | 10.92% | Upgrade
|
| Revenue as Reported | 25,495 | 25,862 | 25,575 | 20,908 | 12,605 | 12,445 | Upgrade
|
| Advertising Expenses | - | 537.6 | 494.86 | 414.75 | 233.74 | 234.1 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.